← FDA DRUG APPROVALS

FDA ANDA · ANDA065159

DISPERMOX

Sponsor: RANBAXY LABS LTD

APPLICATION
ANDA065159
TYPE
ANDA
ORIGINAL APPROVAL
2003-12-04
LATEST ACTION
2003-12-04
ROUTE
ORAL
DOSAGE FORM
TABLET, FOR SUSPENSION
MARKETING STATUS
Discontinued

Products

DISPERMOXDiscontinued
AMOXICILLIN 600MG · TABLET, FOR SUSPENSION · ORAL

Approval history

2003-12-04OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →